Evan Scullin

Chief Medical Officer at Xenoport

Evan Scullin joined Azurity Pharmaceuticals (formerly Arbor Pharmaceuticals, Inc) in 2011 as Medical Director, ultimately becoming Vice President, Medical Affairs in 2020. Before joining Arbor, Evan served as director of business and product development for a privately held pharmaceutical strategy consulting firm, Pharmalogika, based in North Carolina.

Evan has over 20 years combined clinical, research and industry experience in the life sciences field. Evan earned his M.D. at the Royal College of Surgeons in Ireland and subsequently trained at Beaumont Hospital in Dublin. As part of his medical training, Evan conducted epidemiologic research at the US Army Medical Research Unit in Kenya and completed an externship at King’s College London School of Medicine. He has also obtained an Executive Certificate in Business Strategy from the Michael J. Coles College of Business, Kennesaw State University, and holds a B.S. in Biology from Washington and Lee University.


Org chart

Sign up to view 6 direct reports

Get started